Finance

Lists
CRLBF:OTCMKTS
Cresco Labs Inc
0,64 US$
+1,23%
(+0,0078) 1D
9 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRLBF...
Open
0,63 US$
High
0,65 US$
Low
0,62 US$
Mkt. cap
325,20 მლნ.
Avg. vol.
639,52 ათ.
Volume
178,37 ათ.
52-wk high
2,30 US$
52-wk low
0,59 US$
Beta
1,31
Shares outstanding
355,59 მლნ.
No. of employees
3 ათ.
Open
0,63 US$
High
0,65 US$
Low
0,62 US$
Mkt. cap
325,20 მლნ.
Avg. vol.
639,52 ათ.
Volume
178,37 ათ.
52-wk high
2,30 US$
52-wk low
0,59 US$
Beta
1,31
Shares outstanding
355,59 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
47 წუთის წინ
Wall Street split on pioneering S&P 500 stock's price target
Kalkine Media
Kalkine Media
·
53 წუთის წინ
Why Does Strategy (NASDAQ:MSTR) Matter After the Rebound?
Seeking Alpha
Seeking Alpha
·
4 საათის წინ
The 1-Minute Market Report October 10, 2026 (NYSEARCA:VOO)
Profile
Cresco Labs, Inc. is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use. The company's stock trades on the Canadian Securities Exchange under the ticker symbol CL, and in over-the-counter markets in the United States with the ticker symbol CRLBF. Wikipedia
About Cresco Labs Inc
CEO-
Employees2,9 ათ.
Founded2013
Headquartersჩიკაგო, ილინოისი, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
164,91 მლნ.
161,55 მლნ.
151,32 მლნ.
173,34 მლნ.
Cost of goods sold
85,55 მლნ.
78,23 მლნ.
75,88 მლნ.
86,39 მლნ.
Cost of revenue
85,55 მლნ.
78,23 მლნ.
75,88 მლნ.
86,39 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53,53 მლნ.
60,43 მლნ.
59,36 მლნ.
66,63 მლნ.
Operating expense
59,17 მლნ.
65,40 მლნ.
64,28 მლნ.
73,59 მლნ.
Total operating expenses
144,72 მლნ.
143,63 მლნ.
140,15 მლნ.
159,98 მლნ.
Operating income
20,19 მლნ.
17,92 მლნ.
11,17 მლნ.
13,36 მლნ.
Other non operating income
4,21 მლნ.
4,23 მლნ.
1,34 მლნ.
-233,00 ათ.
EBT including unusual items
-10,10 მლნ.
-87,15 მლნ.
-2,79 მლნ.
-3,60 მლნ.
EBT excluding unusual items
10,06 მლნ.
7,62 მლნ.
-2,75 მლნ.
-1,76 მლნ.
Income tax expense
11,87 მლნ.
1,80 მლნ.
14,22 მლნ.
-18,97 მლნ.
Effective tax rate
-117,48%
-2,07%
-508,95%
527,42%
Other operating expenses
-
-
-
-
Net income
-17,05 მლნ.
-87,59 მლნ.
-13,07 მლნ.
16,80 მლნ.
Net profit margin
-10,34%
-54,22%
-8,64%
9,69%
Earnings per share
0,01
-0,03
-0,04
0,06
Interest and investment income
699,00 ათ.
1,30 მლნ.
407,00 ათ.
407,00 ათ.
Interest expense
-15,27 მლნ.
-15,63 მლნ.
-15,33 მლნ.
-15,51 მლნ.
Net interest expenses
-14,57 მლნ.
-14,33 მლნ.
-14,93 მლნ.
-15,10 მლნ.
Depreciation and amortization charges
5,64 მლნ.
4,97 მლნ.
4,92 მლნ.
6,96 მლნ.
EBITDA
33,05 მლნ.
28,68 მლნ.
23,39 მლნ.
26,02 მლნ.
Gain or loss from assets sale
-2,60 მლნ.
352,00 ათ.
-
1,93 მლნ.
AI content may include mistakes. Learn more
Google აპები